Characteristics | Active (n = 33) | Placebo (n = 31) | P-value |
---|---|---|---|
Age, median | 37.2 (23–57) | 36.4 (22–52) | 0.06 |
Women, No. (%) | 22 (66.6) | 21 (67.7) | 0.82 |
Employment status, No. (%) | |||
 Employed or student | 21 (63.6) | 24 (77.4) |  |
 Household | 9 (27.2) | 3 (9.6) | 0.051 |
 Unemployed | 3 (9) | 4 (12.9) |  |
Body mass index, median (IQR) | 18.47 (19.2–30.4) | 20.67 (20.07–27.85) | 0.06 |
Smoking status, No. (%) | |||
 Never | 20 (60) | 17 (54) |  |
 Former | 5 (15) | 6 (19) | 0.36 |
 Current | 8 (24) | 8 (25) |  |
Comorbidities, No. (%) | |||
 Seasonal allergies | 8 (24) | 5 (16) | 0.83 |
 Depression | 4 (12) | 2 (6) | |
 Anxiety | 5 (15) | 4 (13) | |
 Asthma | 2 (6) | 3 (9) | |
 Emotional stress | 5 (15) | 6 (19) | |
 Sleep problems | 7 (21) | 8 (25) | |
Duration of migraine, No. (%) | |||
 ≤ 2 years | 19 (57.6) | 17 (54.8) | 0.216 |
 > 2 years | 14 (42.4) | 14 (45.2) | |
Number of Attacks (mean ± SD) | 4.67 ± 1.05 | 4.61 ± 1.09 | 0.743 |
Pre-treatment Median (IQR) | 5 (2) | 5 (1) | |
Pain Severity (mean ± SD) | 7.85 ± 1.03 | 7.90 ± 0.91 | 0.899 |
Pre-treatment Median (IQR) | 8 (2) | 8 (2) |